Detalhe da pesquisa
1.
Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.
Vaccine
; 32(45): 5967-74, 2014 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25218298